Open AccessIs there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?
Author(s) -
Zohra Layegh,
Femke Hooijberg,
Carla Bastida,
Alwin D. R. Huitema,
Theo Rispens,
Gertjan Wolbink
Publication year - 2022
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/xn5i2y
Subject(s) - medicine , tocilizumab , rheumatoid arthritis , drug , arthritis , pharmacology , intensive care medicine